His main research concerns Immunology, Molecular biology, Peptide sequence, T cell and Antigen. Immunology connects with themes related to CD40 in his study. His biological study spans a wide range of topics, including Cytotoxic T cell, Interleukin 12, Interleukin 21 and Downregulation and upregulation.
His work deals with themes such as Binding site and Peptide, which intersect with Peptide sequence. His research integrates issues of T lymphocyte, Antibody, CCL1 and Monoclonal in his study of T cell. The Antigen study combines topics in areas such as Clone and Allergy.
His primary scientific interests are in Immunology, T cell, Antigen, Epitope and Molecular biology. His T cell study combines topics in areas such as T lymphocyte, CD8, Antibody and Virology. His study in Major histocompatibility complex and Human leukocyte antigen are all subfields of Antigen.
His work in Molecular biology covers topics such as Interleukin 21 which are related to areas like IL-2 receptor and CD40. Francesco Sinigaglia interconnects CC chemokine receptors and CXCL16 in the investigation of issues within CCL5. In his study, Peptide is strongly linked to Peptide binding, which falls under the umbrella field of MHC class II.
Francesco Sinigaglia mainly investigates Immunology, T cell, Cell biology, Chemokine receptor and Chemokine. His Immunology study frequently links to adjacent areas such as Receptor. His T cell research includes themes of Epitope, Antigen and Virology.
As part of the same scientific family, Francesco Sinigaglia usually focuses on Antigen-presenting cell, concentrating on CCL5 and intersecting with CXCL16. His CC chemokine receptors study combines topics from a wide range of disciplines, such as CCL17, CCL13 and CCL1. His research investigates the connection between Interleukin 3 and topics such as Interleukin 12 that intersect with issues in Molecular biology.
Francesco Sinigaglia spends much of his time researching Immunology, Chemokine receptor, Chemokine, CC chemokine receptors and Receptor. His work on Immunology deals in particular with T cell, CXCL10, Interleukin 4 and Proinflammatory cytokine. His Chemokine receptor study incorporates themes from Autoimmunity and Disease.
His studies deal with areas such as Tumor necrosis factor alpha, Interferon gamma and CD40 as well as Chemokine. His CC chemokine receptors research is multidisciplinary, relying on both CCL17, CCL13, CCL5 and CCL1. The concepts of his CCL17 study are interwoven with issues in Cytotoxic T cell, Antigen-presenting cell, CCL28, CXCL16 and Chemokine receptor CCR5.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells
Andrea Iellem;Margherita Mariani;Rosmarie Lang;Helios Recalde.
Journal of Experimental Medicine (2001)
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D D'Ambrosio;M Cippitelli;M G Cocciolo;D Mazzeo.
Journal of Clinical Investigation (1998)
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
Tiziana Sturniolo;Elisa Bono;Jiayi Ding;Laura Raddrizzani.
Nature Biotechnology (1999)
Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
Daniele D’Ambrosio;Andrea Iellem;Raffaella Bonecchi;Daniela Mazzeo.
Journal of Immunology (1998)
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.
Paola Panina-Bordignon;Daniela Mazzeo;Pietro Di Lucia;Daniele D'Ambrosio.
Journal of Clinical Investigation (1997)
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
Paola Panina-Bordignon;Alberto Papi;Margherita Mariani;Pietro Di Lucia.
Journal of Clinical Investigation (2001)
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.
Alessandra Zingoni;Hortensia Soto;Joseph A. Hedrick;Antonella Stoppacciaro.
Journal of Immunology (1998)
Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor).
M K Gately;B B Desai;A G Wolitzky;P M Quinn.
Journal of Immunology (1991)
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
F. Sinigaglia;M. Guttinger;J. Kilgus;D. M. Doran.
Nature (1988)
Increased Expression of the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
Marina Saetta;Margherita Mariani;Paola Panina-Bordignon;Graziella Turato.
American Journal of Respiratory and Critical Care Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Ferrara
Roche (Switzerland)
Humanitas University
Roche (Switzerland)
Sapienza University of Rome
Université Paris Cité
University of Ferrara
University of Milano-Bicocca
Flinders University
Mario Negri Institute for Pharmacological Research
Independent Scientist - Australia
Chalmers University of Technology
University of Trieste
Centre national de la recherche scientifique, CNRS
Binghamton University
University of Washington
Sungkyunkwan University
University of Melbourne
University of Bonn
University of Duisburg-Essen
University of California, Los Angeles
University of Zurich
University of Valencia
University Hospital Bonn
Memorial Sloan Kettering Cancer Center
TextProject